Key facts
- This page summarizes Charles Cherington's Form 4 filing for Comera Life Sciences Holdings, Inc..
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 03 Jan 2024, 20:38.
Charles Cherington - 27 Dec 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 27 Dec 2023
- Net transaction value
- +$1,948,332,900
- SEC form
- 4
- Accepted by SEC
- 03 Jan 2024, 20:38:12 UTC
- Prior SEC filing
- 20 Dec 2023
- Next SEC filing
- 05 Nov 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Charles Cherington
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Charles Cherington filed Form 4 for Comera Life Sciences Holdings, Inc. on 03 Jan 2024.
Change
- Previous filing in this sequence was filed on 20 Dec 2023.
- Current net transaction value: +$1,948,332,900.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CMRA
transaction
Derivative
12.0% Senior Secured Convertible Notes
Purchase
- Transaction value
- $567,900
- Shares
- Change %
- Price
- Shares after
- $567,900
- Date
- 29 Dec 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,325,454
- Exercise price
- $0.0550
- Footnotes
- F1
CMRA
transaction
Derivative
Warrants to Purchase Common Stock
Purchase
- Transaction value
- $0
- Shares
- +20,650,908
- Change %
- Price
- $0.000000
- Shares after
- 20,650,908
- Date
- 29 Dec 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,650,908
- Exercise price
- $0.0550
- Footnotes
- F1
CMRA
transaction
Derivative
Series A Convertible Perpetual Preferred Stock
Purchase
- Transaction value
- $1,947,765,000
- Shares
- +3,896
- Change %
- Price
- $500000.00*
- Shares after
- 3,896
- Date
- 27 Dec 2023
- Ownership
- By LLC
- Underlying class
- Common Stock
- Underlying amount
- 310,153
- Exercise price
- $12.56
- Footnotes
- F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The reporting person entered into a Securities Purchase Agreement with the Issuer on December 29, 2023, pursuant to which the reporting person acquired (i) $567,900 principal amount of the Issuer's 12.0% Senior Secured Convertible Notes (the "Notes") and (ii) 20,650,908 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.0001 per share ("Common Stock"), at an exercise price of $0.055 per share (the "Warrants"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof.
Footnote F2
The preferred stock was acquired by Comera SPV LLC ("SPV") in a private transaction pursuant to a purchase agreement, dated as of December 27, 2023, with an unaffiliated, institutional investor.
Footnote F3
The preferred stock is perpetual and therefore has no expiration date.
Footnote F4
The reporting person is the General Partner of SPV. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.